Description

Learning Objectives:

• Identify recent advances in the use of nuclear imaging and electrogram guidance to distinguish specific causes of cardiomyopathy
• To understand current and future imaging approaches to direct therapy in cardiac sarcoidosis
• To discuss important recommendations in the recently published Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

10:30 - 10:50 - Imaging in Unexplained Cardiomyopathy: A Clinician's Perspective

10:50 - 11:10 - Non-invasive Imaging for Cardiac Sarcoidosis: the European Perspective

11:10 - 11:30 - PET/CT for Detection and Management of Sarcoidosis: Update from the new Guidelines

11:30 - 12:00 - What's Next for Imaging to Direct Therapy in Cardiac Sarcoidosis: Current and Future Approaches

Moderator(s):

• Ron Blankstein, MD, FASNC, Brigham & Women's Hospital
• Robert J. Gropler, MD, MASNC, Washington University

Speaker(s):

• Leslie T. Cooper, MD, Mayo Clinic
• Hein J. Verberne, MD, PhD, Academic Medical Center
• Panithaya Chareonthaitawee, MD, Mayo Clinic
• David Birnie, MD, Ottawa Heart Inst.